Institutional members access full text with Ovid®

LVAD: LEFT VENTRICULAR ASSIST DEVICES for end-stage heart failure

Laing, Craig MSN, RN, ANP-BC

doi: 10.1097/01.NPR.0000441913.24525.19
Feature: MECHANICAL CIRCULATORY DEVICES

Abstract: Heart failure affects more than 5 million Americans with approximately 200,000 patients in end-stage disease that has failed traditional treatment. Historically, the only option for treatment was a heart transplant until left ventricular assist devices offered another option.

Heart failure affects more than 5 million Americans with approximately 200,000 patients in end-stage disease that has failed traditional treatment. Historically, the only available treatment was a heart transplant until left ventricular assist devices offered another option.

Craig Laing is a nurse practitioner at Christiana Care Cardiology Consultants, Christiana Care Health System, Newark, Del.

The author has disclosed that he has no financial relationships related to this article.

© 2014 Lippincott Williams & Wilkins